Search
Partnering with Genezen
When therapies are as important to patients as cell and gene therapies, it is important to choose the right CMC partner from the start. As Chairman & CEO Steve Favaloro describes, Genezen has been successfully partnering with companies both large and small, and would love to partner with you. Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art viral vector facilities in Lexington, MA and Indianapolis, IN. If you need help with your AAV, LVV o
2 days ago


Out today: HSBC Innovation Banking's Jon Norris shares highlights from the 2025 HSBC Venture Healthcare Full-Year Report
His widely read report shows the data behind what venture deals got done last year, who are the venture investors that have been most active in deploying capital, the fundraising and IPO environment, and which technologies and indications are seeing the most investor interest. DOWNLOAD THE FREE REPORT #sponsored
2 days ago


This year, our industry has seen many programs held up by CMC issues. As Genezen Chairman & CEO Steve Favaloro describes, having a quality and compliance mindset is key
Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art viral vector facilities in Lexington, MA and Indianapolis, IN. If you need help with your AAV, LVV or RVV project, please reach out! www.Genezen.com #sponsored
Dec 18, 2025


Scott Hemphill, Site Head of Genezen's Lexington, MA viral vector facility, reflects on the investments and improvements the company has made over the past year
Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art viral vector facilities. If you need help with your AAV, LVV or RRV project, please reach out! www.Genezen.com #sponsored
Dec 9, 2025


Allucent’s new Chief Operating Officer, Patrick Phillips, discusses why choosing the right CRO is essential for small and mid-size biopharma companies
He highlights Allucent’s specialized expertise, global presence in more than 60 countries, and innovative application of AI to advance clinical development and improve operational efficiency. #sponsored
Nov 10, 2025


New Sponsor Announcement: We are thrilled to announce Evaluate as a new sponsor of BiotechTV
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth. Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and an
Oct 30, 2025


Savills has published a new report - U.S. Life Sciences State of the Market 2025
We spoke with Brianna Friedman from the research team to go behind the numbers and learn how today's environment for life sciences is...
Oct 10, 2025


Michael White, Head of Life Sciences & Healthcare, UK & Nordics at HSBC Innovation Banking, shares insights from his team's UK & Nordics: Life Sciences & Healthcare 1H 2025 Venture Financing Report
The report is full of data that shows where venture money is being invested in the region and by which investors, and includes these...
Sep 10, 2025


Visiting Genezen Indianpolis to see where it all started - and where the company today makes lenti and retroviral vectors for cell and gene therapies
BiotechTV visited our sponsor Genezen's Indianapolis facility last week where they manufacture lenti and retroviral vectors for gene and...
Aug 13, 2025


Jon Norris shares highlights from his 2025 Mid-Year Venture Healthcare Report
He discusses trends in deal size, therapeutic focus, IPOs, and more. DOWNLOAD THE FULL REPORT #sponsored
Jul 21, 2025


Welcoming Genezen to the BiotechTV family today as a new sponsor
Genezen is a best-in-class CDMO with over a decade of experience and state-of-the-art viral vector facilities. Genezen's advanced...
Jun 16, 2025
Klein Hersh at #ASCO25
Lonnie Brantz, Zach Spitz, and Jeffrey Azarva stopped by to discuss oncology trends, the evolving talent landscape, and the importance of...
Jun 2, 2025


GENESIS Pharma is bringing global innovation closer to patients in Central and Eastern Europe
Already a partner for many of the world's top biopharma companies in this important region, see how GENESIS Pharma can help your company...
May 20, 2025


Meet NewBiologix, an innovative Swiss biotech company dedicated to revolutionizing the field of gene therapy
At #ASGCT2025, we met up with Founder and CEO Igor Fisch, who described the pillars that make NewBiologix a partner of choice in the rAAV...
May 16, 2025


Teresa Nunes, M.D., MSC, MBA, Chief Medical Officer at Allucent, explores her role and the therapeutic areas she supports, with a focus on neuroscience
She shares how Allucent’s deep experience in neuro-related clinical trials helps small and mid-sized biotech companies overcome complex...
Apr 30, 2025


Allucent: Alex MacDonald, VP, Global Head of Model-Informed Drug Development at Allucent, discusses how his team supports biotech companies throughout the drug development journey
From the role of Clinical Pharmacology Modeling and Simulation to designing smarter early-phase studies and anticipating emerging trends,...
Apr 23, 2025


Checking in on the progress of Trinity by Breakthrough in Oxford, UK
After its recent topping off ceremony, BiotechTV's Amy Brown checked in on the construction progress of Trinity by Breakthrough...
Apr 8, 2025


HSBC Innovation Banking: Q1 2025 Venture Numbers for Healthcare
HSBC's Jonathan Norris shares an update on Q1 venture numbers for healthcare, and how the venture side of the sector is holding up in...
Apr 4, 2025


At the recent Timmerman Report west coast anniversary celebration, HSBC Innovation Banking's Jesse Essaff discussed Seattle's venture environment and how HSBC helps entrepreneurs
A director at HSBC Innovation Banking for biopharma, diagnostics, and tools, he shares the data on the current environment both for...
Mar 25, 2025


Introducing The Savills Studio, a great space in the Prudential Tower that is home to the Boston life sciences team, and is available for clients and future clients to use for work or events
Reach out to learn more about how this expert team can help you find and build out your lab space. Featuring: Chris Gorczyca | Corporate...
Mar 10, 2025








.png)




